(Burroughs-Wellcome Inc) said it plansto invest 10 mln dlrs in research and development-relatedactivities over the next five years if changes planned toCanada's patent act become law.    The company said it would increase its commitment toclinical research if the patent act is changed to providefurther protection for patent rights, as planned. Reuter&#3;